companydata.dkNORDIC BIOTECH PRIVATE INVESTORS ApS: Financial statements 2022
CVR: 26284384
NORDIC BIOTECH PRIVATE INVESTORS ApS (CVR 26284384) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK -20,000 and a net result of DKK -1,036,850 compared with DKK -167,628 the year before. Equity amounted to DKK 1,474,445. The solvency ratio was 98.9%.
- Gross Profit
- -20,000 kr.
- Profit/Loss
- -1,036,850 kr.
- Equity
- 1,474,445 kr.
- Total Assets
- 1,490,444 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | -20 t. | -1 mio. | 1.5 mio. | 0 |
| 2021 | - | -15 t. | -168 t. | 2.5 mio. | 0 |
| 2020 | - | -16 t. | -55 t. | 2.7 mio. | - |
| 2019 | - | -29 t. | 262 t. | 2.7 mio. | - |
| 2018 | - | -24 t. | -10.6 mio. | 2.5 mio. | 0 |
Keep an eye on NORDIC BIOTECH PRIVATE INVESTORS ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
NORDIC BIOTECH PRIVATE INVESTORS ApS has published its annual report for 2021. Gross profit came to DKK -15,250, and the net result was DKK -167,628.
About NORDIC BIOTECH PRIVATE INVESTORS ApS
NORDIC BIOTECH PRIVATE INVESTORS ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2001. The company was registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Mosegaard Larsen. The company's owners include Thue Walter Schwartz, Peter Moldt and Dorte Kloppenborg Skrumsager. In 2025, the company reported a gross profit of DKK -432,293 and a net result of DKK -571,396 compared with DKK 2,080,087 the year before. Equity amounted to DKK 2,975,449.